Pharmacologic fibroblast reprogramming into photoreceptors restores vision

Area of Science:

• Ophthalmology and Regenerative Medicine
• Cellular Reprogramming and Vision Restoration

Background:

• Retinopathies cause irreversible blindness through photoreceptor cell loss, with no current treatments to restore vision.
• Generating specific neuronal subtypes, like photoreceptors, from other cell types via chemical reprogramming remains a significant challenge.

Purpose of the Study:

• To investigate the potential of chemical reprogramming to generate functional photoreceptor-like cells from fibroblasts.
• To assess the therapeutic efficacy of transplanted chemically induced photoreceptor-like cells (CiPCs) in a mouse model of retinal degeneration.

Main Methods:

• Administration of a specific cocktail of five small molecules to induce fibroblast transformation into photoreceptor-like cells.
• Subretinal transplantation of CiPCs into Pde6b-deficient (rd1) mice, a model for rod degeneration.
• Evaluation of visual function restoration using pupil reflex tests and assessment of underlying molecular mechanisms, including mitonuclear communication.

Main Results:

• Successful chemical induction of fibroblasts into rod photoreceptor-like cells (CiPCs).
• Transplantation of CiPCs led to partial restoration of pupil reflex and visual function in rd1 mice.
• Mitonuclear communication, involving AXIN2 translocation to mitochondria, reactive oxygen species production, NF-κB activation, and Ascl1 upregulation, was identified as crucial for CiPC generation.

Conclusions:

• Chemical reprogramming offers a viable strategy for generating photoreceptor-like cells.
• CiPCs demonstrate therapeutic potential for vision restoration in models of inherited retinal diseases.
• Understanding mitonuclear communication pathways is key to advancing cell-based therapies for blindness.